{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:11:58Z","timestamp":1791612718391,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.japh.2025.102384","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:29:31Z","timestamp":1741116571000},"page":"102384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["TikTok\u2019s take on adverse effects for glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1200-6867","authenticated-orcid":false,"given":"Gwendolyn A.","family":"Wantuch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-1517","authenticated-orcid":false,"given":"Jerica","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2025.102384_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.japh.2023.10.002","article-title":"Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022","volume":"64","author":"Watanabe","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2025.102384_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/asj\/sjad211","article-title":"Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: a google trends analysis","volume":"44","author":"Han","year":"2023","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.japh.2025.102384_bib4","author":"DeSilver"},{"key":"10.1016\/j.japh.2025.102384_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.puhe.2022.10.010","article-title":"TikTok: a far-reaching opportunity for health professionals to address weight loss","volume":"213","author":"Samuel","year":"2022","journal-title":"Public Health"},{"key":"10.1016\/j.japh.2025.102384_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/postmj\/qgae021","article-title":"The emergence of MedTok: a qualitative analysis of popular medical TikTok videos","author":"Rosen","year":"2024","journal-title":"Postgrad Med J"},{"issue":"9","key":"10.1016\/j.japh.2025.102384_bib9","doi-asserted-by":"crossref","DOI":"10.2196\/30409","article-title":"TikTok as a health information source: assessment of the quality of information in diabetes-related videos","volume":"23","author":"Kong","year":"2021","journal-title":"J Med Internet Res"},{"issue":"5","key":"10.1016\/j.japh.2025.102384_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/ijamh-2020-0111","article-title":"COVID-19 on TikTok: harnessing an emerging social media platform to convey important public health messages","volume":"34","author":"Basch","year":"2022","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.japh.2025.102384_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2022.06.030","article-title":"Examination of information and misinformation about urinary tract infections on TikTok and YouTube","volume":"168","author":"Tam","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.japh.2025.102384_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2024.105426","article-title":"Quality assessment of health science-related short videos on TikTok: a scoping review","volume":"186","author":"Li","year":"2024","journal-title":"Int J Med Inform"},{"issue":"1","key":"10.1016\/j.japh.2025.102384_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med"},{"issue":"8","key":"10.1016\/j.japh.2025.102384_bib15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2105\/AJPH.2007.124537","article-title":"Adverse event detection in drug development: recommendations and obligations beyond phase 3","volume":"98","author":"Berlin","year":"2008","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.japh.2025.102384_bib16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/ohn.688","article-title":"A social media quality review of popular sinusitis videos on TikTok","volume":"170","author":"Dimitroyannis","year":"2024","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.japh.2025.102384_bib17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/journalmedia5030088","article-title":"Research on health. Topics communicated through TikTok: a systematic review of the literature","volume":"5","author":"Sattora","year":"2024","journal-title":"Journalism Media"},{"key":"10.1016\/j.japh.2025.102384_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.puhe.2017.06.016","article-title":"An exploratory assessment of weight loss videos on YouTube","volume":"151","author":"Basch","year":"2017","journal-title":"Public Health"},{"issue":"11","key":"10.1016\/j.japh.2025.102384_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jac5.2035","article-title":"Evaluation of TikTok social media posts on side effect information for popular weight loss medications","volume":"7","author":"Singleton","year":"2024","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.japh.2025.102384_bib25","series-title":"version 16.86. Redmond, WA","year":"2024"},{"key":"10.1016\/j.japh.2025.102384_bib26","series-title":"SPSS Statistics for Windows [computer software]. version 28.0","year":"2021"},{"issue":"7 Pt 2","key":"10.1016\/j.japh.2025.102384_bib27","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00019","article-title":"Short-term medical benefits and adverse effects of weight loss","volume":"119","author":"Pi-Sunyer","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.japh.2025.102384_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15563650.2019.1606432","article-title":"Toxicity induced by multiple high doses of vitamin B12 during pernicious anemia treatment: a case report","volume":"58","author":"Morales-Gutierrez","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"issue":"8","key":"10.1016\/j.japh.2025.102384_bib29","doi-asserted-by":"crossref","DOI":"10.5070\/D3268049797","article-title":"Acne related to dietary supplements","volume":"26","author":"Zamil","year":"2020","journal-title":"Dermatol. Online J"},{"issue":"1","key":"10.1016\/j.japh.2025.102384_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jocd.12360","article-title":"Acneiform eruptions caused by vitamin B12: a report of five cases and review of the literature","volume":"17","author":"Veraldi","year":"2018","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.japh.2025.102384_bib31","doi-asserted-by":"crossref","DOI":"10.2196\/29422","article-title":"Patient influencers: the next frontier in direct-to-consumer pharmaceutical marketing","volume":"24","author":"Willis","year":"2022","journal-title":"J Med Internet Res"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T23:13:24Z","timestamp":1754349204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1544319125000639"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102384","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TikTok\u2019s take on adverse effects for glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102384"}}